Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Magic Mushroom Drug Helps Cancer Patients Chill Out

Duration: 00:54s - Published: < > Embed
News video: Magic Mushroom Drug Helps Cancer Patients Chill OutThe "magic mushroom" drug psilocybin can help cancer patients relax and feel less distressed about their disease, two teams of doctors reported Thursday. The drug eased anxiety and depression in 80 percent of the patients who took it in the studies, and many described their one-time sessions as ranking among the most meaningful experiences of their lives. Dr. Stephen Ross, director of addiction psychiatry at New York University's Langone Medical Center, gave the following statement to NBC news.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium (Paris)

Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium (Paris)*Business Wire India*Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium...
Business Wire India - Press Releases

Scientists develop tanning drug that could prevent cancer

Scientists develop tanning drug that could prevent cancer Researchers at Massachusetts General...
WorldNews - Front Page

First-line immunotherapy treatment can improve survival for subset of lung cancer patients

Findings from a phase III clinical trial for advanced lung cancer patients could help oncologists...
Science Daily - Science

Clovis Oncology to raise US$250mln to build on ovarian cancer trial success

Clovis Oncology Inc (NASDAQ:CLVS) is wasting no time in raising funds for its application for ovarian...
Proactive Investors - BusinessAlso reported by •Reuters


Medlab Clinical to begin trials of cannabis based medicines

Medlab Clinical (ASX:MDC) has received approvals to begin human trials of two different cannabis...
Proactive Investors - Business

Inhibitor drug improves overall survival in older radioiodine resistant thyroid cancer

The drug lenvatinib can significantly improve overall survival rates in a group of thyroid cancer...
Science Daily - Science

TG Therapeutics boosted by leukemia drug trial

TG Therapeutics Inc (NASDAQ:TGTX) shares advanced in pre-market dealing after it revealed results...
Proactive Investors - Business

DelMar Pharmaceuticals races up on Nasdaq on brain cancer clinical trial news

Shares in Cancer therapy focused firm DelMar Pharmaceuticals (NASDAQ: DMPI) added over 19% to $2.21...
Proactive Investors - Business

FDA moves to clear path for drugs aimed at cancer-causing genes

[...] in a long-awaited move, U.S. drug regulators will simplify the approval of treatments targeting...
SFGate - Business

Existing drugs could benefit patients with bone cancer, genetic study suggests

A subgroup of patients with osteosarcoma -- a form of bone cancer -- could be helped by an existing...
Science Daily - Science


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+